Adenosine stimulates anion secretion across cultured and native adult human vas deferens epithelia.
Experiments were conducted to determine the responsiveness of human vas deferens epithelial cell monolayers to adenosine and related agonists. Human abdominal vas deferens epithelial cells have been isolated from adult tissues and grown to confluence on permeable supports. All cells exhibit intense ZO-1 and cytokeratin immunoreactivity. Cultured cell monolayers exhibit high electrical resistance with a lumen-negative potential difference and short circuit current (I(sc)) indicative of anion secretion and/or cation absorption. A portion of the basal I(sc) is inhibited by amiloride. Amiloride-sensitive I(sc) is enhanced by exposure to glucocorticoids and is Na(+) dependent, indicating the presence of epithelial sodium channel-mediated Na(+) absorption. Epithelial anion secretion and intracellular generation of cAMP are acutely stimulated by adenosine and the adenosine receptor agonist 5'-(N-ethylcarboxamido)adenosine (NECA), with these effects being fully blocked by 8-phenyltheophylline. Adenosine receptors are localized to the apical membrane of the epithelial cells, as basolateral adenosine is without effect. Freshly excised human vas deferens recapitulate observations made on cultured epithelia when evaluated with the self-referencing vibrating probe: amiloride inhibition of basal ion transport, stimulation by adenosine, and inhibition by 8-phenyltheophyline. These results demonstrate that adult human vas deferens epithelium actively transports ions to generate the luminal environment of the deferent duct. Thus, vas deferens epithelium likely plays an active role in male fertility, and interventions that modulate epithelial function might be exploited to treat male-factor infertility or in contraception.
Carlin
Ryan W
RW
Department of Anatomy and Physiology, Kansas State University, Manhattan, Kansas 66502-5802, USA.
Lee
Jun Ho
JH
Marcus
Daniel C
DC
Schultz
Bruce D
BD
D000241:Adenosine / Q000819:agonists / Q000494:pharmacology*; D019830:Adenosine-5'-(N-ethylcarboxamide) / Q000494:pharmacology; D000328:Adult; D000584:Amiloride / Q000494:pharmacology; D000838:Anions / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D004847:Epithelial Cells / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D017136:Ion Transport / Q000187:drug effects* / Q000502:physiology; D007633:Keratins / Q000378:metabolism; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D008565:Membrane Proteins / Q000378:metabolism; D010750:Phosphoproteins / Q000378:metabolism; D018047:Receptors, Purinergic P1 / Q000378:metabolism; D014649:Vas Deferens / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D062826:Zonula Occludens-1 Protein
D000838:Anions; D008565:Membrane Proteins; D010750:Phosphoproteins; D018047:Receptors, Purinergic P1; C569042:TJP1 protein, human; D062826:Zonula Occludens-1 Protein; D019830:Adenosine-5'-(N-ethylcarboxamide); D007633:Keratins; D000584:Amiloride; D000242:Cyclic AMP; D000241:Adenosine